Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

GPs to take central role in FH screening programme

By Nigel Praities

GPs will play a major role in screening children at risk of familial hypercholesterolaemia in NICE guidelines due to be released next week.

Around one in 500 people have FH, but only around 10% of these have been identified with the potentially life-threatening genetic disorder.

The new guidance from NICE hopes to improve the identification of people with FH and recommends all children with affected parents should be referred for a genetic test before the age of 10.

Dr Jonathan Morrell, a GP in Hastings, East Sussex, and a hospital practitioner in cardiology, said the average practice may have several families on their lists affected by the disease and GPs would not be expected to refer them for genetic testing.

‘No GPs are doing gene testing and a lot will not think of the wider implications in the family. But these new guidelines will mean primary care will have to identify patients with FH and then ensure their families have gene testing,' he said.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say